Lorenz Bastian

20PUBLICATIONS
111CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Bioinformatic methods developmentGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 19, 2026
Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL.

|Apr 20, 2026
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Mar 13, 2026
IDH2 clonal hematopoiesis and IKAROS loss cooperate in a B-ALL subtype after lenalidomide therapy for multiple myeloma.

Johanna M Horns, Thomas Beder, Axel Künstner

|Feb 26, 2026
Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Alina M Hartmann, Lorenz Bastian, Malwine J Barz

|Jan 06, 2026
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia.

Sophie Steinhäuser, Thomas Beder, Emely Hübner

Pageof 4

Frequent Collaborators

7 joint publications

Claudia Dorothea Baldus

5 joint publications

Nicola Gökbuget

5 joint publications

Monika Brüggemann

4 joint publications

Thomas Beder